Bionic ear manufacturer Cochlear (ASX: COH) is pressing ahead building a new factory in China and moving to human trials of a breakthrough new fully implantable cochlear device. Chairman Rick Holliday-Smith told Cochlear’s annual general meeting that ‘sound’ progress had been made developing its new Chinese manufacturing facility in Chengdu (pictured). He said the project…
Today I spoke at the National Press Club on a topic close to my heart: Industry 4.0.
I opened by saying that the most important topic the nation can focus on is preparing for the 4th industrial revolution – or as the Germans call it, Industrie 4.0.
A short documentary marking 50 years of containerisation and its role in the Australian economy has been launched by trade minister Simon Birmingham.
By Stuart Corner A Dunedin based company, Iris Data Science, aims to develop what it says will be the world’s first sheep facial recognition software, eliminating the need for electronic identification or ear tagging. It will prototype the technology this year after receiving a $40,000 grant from the New Zealand Government’s innovation agency, Callaghan Innovation,…
Sydney’s Suba Engineering has taken another step in its journey from importer to fully fledged product developer and manufacturer with the delivery of its first SubaLaser industrial marker. Suba’s owner Heinz Zimmerman showed off the locally developed marker at his Melbourne office this week (pictured). Zimmerman said: “We showed our SubaLaser marker prototype just over…
Right now, two projects have been proposed to import gas from overseas to supply eastern Australia. This is an absurd prospect. Australia is a resource-rich country, and exports more gas than any other nation. Why then, would we need to ship it in?
Sydney anti-cancer treatment company Noxopharm (ASX: NOX) has reported anti-cancer effects of its Veyonda treatment in a small group of patients suffering advanced prostate cancer. The 14 patients’ cancers were metastatic and they had exhausted all treatment options when given Veyonda in association with low-dosage radiation in a single lesion. After six months, cancer progression…
Rare earths producer Lynas Corp is confident of a future operating in Malaysia following the extension of its licence to operate by six months. The company said in an operational update that the extension, announced in August, provided an operational pathway for continued operation. However the company has yet to receive further approvals following concerns…
Brent Balinski spoke to officials from Singapore’s science and research agency about collaborative R&D approaches at one public/private centre focussed on advanced manufacturing.
Comment by Peter Roberts Parliament has passed legislation killing the low cost innovation patent system, bowing to arguments from the Productivity Commission. Legislation killing the patent was passed by the Senate last week and followed an essentially economically-focused review that lacked transparency. This is yet another victory in a long list of destructive wins by…
